main navigation
MSGPP - Home
Project Description
  Flow Diagrams
Contact Information
  Program Project Members
Target Diseases & Organisms
* Malaria
   Plasmodium falciparum
   Plasmodium vivax
* Chagas' Disease
    [American Trypanosomiasis]
   Trypanosoma cruzi
* Sleeping Sickness
    [African Trypanosomiasis]
   Trypanosoma brucei
* Leishmaniasis
   Leishmania spp.
* Amoebiasis
   Entamoeba histolytica
* Giardiasis
   Giardia lamblia
* Toxoplasmosis
   Toxoplasma gondii
* Cryptosporidiosis
   Cryptosporidium parvum
Genome Databases
Target Progress
Ligand Screening
Papers by MSGPP
Related Links/Resources
MSGPP

GIARDIASIS
Giardia lamblia


Giardiasis (Giardia lamblia):An enteric pathogen, Giardia has a huge impact on global health by causing diarrhea and exacerbating malnutrition, particularly in children. This pathogen causes chronic symptoms even in immune competent individuals and can be difficult to eradicate with currently available treatments. As a threat to public water and food supplies, Giardia is listed as a category B Biodefense agent..


Organism Giardia lamblia
At Risk Anyone worldwide
Humans Infected worldwide, 15 - 30% prevalence in 3rd world
Disease Outcome
Vaccine Prospects  
Available Drugs Several available, toxic
Drug Resistance Documented

 

General Information: Medline, Centers for Disease Control